Coeptis Therapeutics, Inc. (COEP)
NASDAQ·Healthcare·Biotechnology
$16.62
+0.93%
Mkt Cap $44.73M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | — | $862.05K | — | -$0.80 | -$0.12 | +85.00% | — | — |
| Q4 2025 Nov 13, 2025 | — | $237.44K | — | — | -$0.58 | — | — | — |
| Q3 2025 Aug 14, 2025 | — | $200.68K | — | — | -$1.17 | — | — | — |
| Q2 2025 May 14, 2025 | — | $62.87K | — | — | -$1.11 | — | — | — |
| Q1 2025 Mar 28, 2025 | — | $1.86M | — | -$0.80 | -$1.01 | -26.51% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.05 | -$0.05 | +0.00% | — | — |
| Q3 2024 Aug 16, 2024 | — | — | — | -$0.09 | -$0.08 | +11.11% | — | — |
| Q2 2024 May 10, 2024 | — | — | — | — | -$0.08 | — | — | — |
| Q1 2024 Mar 26, 2024 | — | $1.50M | — | — | -$0.11 | — | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | — | -$0.23 | — | — | — |
| Q3 2023 Aug 11, 2023 | — | — | — | -$0.12 | -$0.08 | +33.33% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | — | -$0.46 | — | — | — |
| Q1 2023 Mar 29, 2023 | — | — | — | — | -$0.20 | — | — | — |
| Q4 2022 Nov 18, 2022 | — | — | — | — | -$0.28 | — | — | — |
| Q3 2022 Aug 2, 2022 | — | — | — | — | -$0.48 | — | — | — |
| Q2 2022 May 12, 2022 | — | — | — | — | -$166752.00 | — | — | — |
| Q1 2022 Mar 11, 2022 | — | — | — | — | -$0.30 | — | — | — |
| Q4 2021 Nov 15, 2021 | — | $9.89K | — | — | -$0.29 | — | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | — | -$0.13 | — | — | — |
| Q2 2021 May 18, 2021 | — | $75.00K | — | — | -$0.10 | — | — | — |